| |
| |
|
| Insider
Information: |
Carmine Bryce D. |
| Relationship: |
EVP and Pres, Lilly Bi... |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
51,186 |
|
|
Indirect Shares
|
6,869 |
|
|
| Direct
Value |
$39,413,220 |
|
|
|
Indirect Value
|
$5,289,130 |
|
|
| Total
Shares |
58,055 |
|
|
| Total
Value |
$44,702,350 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
EVP and Pres, Lilly Bi... |
2011-12-29 |
51,186 |
2011-12-29 |
6,869 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
EVP, Global Marketing & SalesO |
• – – |
2008-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,228 |
|
- |
|
| LLY |
Eli Lilly & Co |
EVP, Global Marketing & SalesO |
• – – |
2008-04-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,313 |
|
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Est Markets BUOf |
• – – |
2008-04-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
40,136 |
|
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-12-20 |
5 |
GD |
$0.00 |
$0 |
D/D |
20 |
51,206 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-12-29 |
5 |
GD |
$0.00 |
$0 |
D/D |
20 |
51,186 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-12-16 |
5 |
GD |
$0.00 |
$0 |
D/D |
40 |
51,226 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-12-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
45 |
63,295 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-06-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
55 |
86,252 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-12-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
60 |
63,235 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-12-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
105 |
63,130 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-05-03 |
5 |
GD |
$0.00 |
$0 |
D/D |
145 |
75,090 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-08-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
145 |
74,153 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-04-28 |
5 |
GD |
$0.00 |
$0 |
D/D |
175 |
75,235 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Est Markets BU |
• – – |
2009-12-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
244 |
38,035 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP, Global Marketing & Sales |
• – – |
2008-12-08 |
5 |
GD |
$0.00 |
$0 |
D/D |
285 |
39,631 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP, Global Marketing & Sales |
• – – |
2008-06-17 |
5 |
GD |
$0.00 |
$0 |
D/D |
312 |
39,916 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-03-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
330 |
75,410 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-07-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
554 |
85,698 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Est Markets BU |
• – – |
2009-03-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
630 |
38,909 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Est Markets BU |
• – – |
2009-06-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
630 |
38,279 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-06-21 |
5 |
GD |
$0.00 |
$0 |
D/D |
1,160 |
73,930 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-08-16 |
4 |
AS |
$35.33 |
$109,523 |
D/D |
(3,100) |
72,640 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-09-16 |
4 |
AS |
$35.55 |
$110,205 |
D/D |
(3,100) |
69,540 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-10-15 |
4 |
AS |
$37.65 |
$116,715 |
D/D |
(3,100) |
66,440 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-11-16 |
4 |
AS |
$34.43 |
$106,733 |
D/D |
(3,100) |
63,340 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
